XML 30 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Revenue $ 205,202 $ 166,939 $ 163,153
Costs of sales 141,007 112,913 116,880
Gross profit 64,195 54,026 46,273
Operating expenses:      
Sales and marketing 8,908 6,935 6,571
Technology and product development 21,877 15,935 15,094
General and administrative 30,519 35,754 40,083
Investigation, proxy solicitation and restatement expenses 1,196 0 19,810
Depreciation and amortization 4,352 4,107 4,307
Total operating expenses 66,852 62,731 85,865
Operating loss (2,657) (8,705) (39,592)
Other income (expense):      
Interest income 1,884 1,159 1,595
Interest expense (524) (4,013) (2,597)
Other income (expense) (220) 3,224 0
Total other income (expense), net 1,140 370 (1,002)
Loss before income taxes (1,517) (8,335) (40,594)
Provision for income taxes (186) (370) (1)
Net loss (1,703) (8,705) (40,595)
Preferred dividends (668) (668) (668)
Net loss applicable to common shares $ (2,371) $ (9,373) $ (41,263)
Net loss per common share      
Basic (in USD per share) $ (0.03) $ (0.14) $ (0.66)
Diluted (in USD per share) $ (0.03) $ (0.14) $ (0.66)
Weighted average number of common shares outstanding used to compute net loss per share applicable to common shares      
Basic (in shares) 71,091,790 67,002,438 62,980,193
Diluted (in shares) 71,091,790 67,002,438 62,980,193
Subscription and transaction fees      
Revenue $ 168,850 $ 139,242 $ 133,167
Costs of sales 103,392 83,617 82,980
Equipment sales      
Revenue 36,352 27,697 29,986
Costs of sales $ 37,615 $ 29,296 $ 33,900